ITN Transplant Data at American Transplant Congress 2012

May 31, 2012

Data from two ITN transplant trials will be reported at the upcoming American Transplant Congress (ATC) meeting in Boston, MA on June 2-6, 2012.

Preliminary results from the A-WISH ITN030ST study, which examines feasibility of immunosuppression withdrawal in hepatitis C or non-immune non-viral liver transplant patients, will be reported in the abstract:

  • Initial outcomes of ITN030ST: Early post-liver transplant immunosuppression withdrawal (Abraham Shaked, MD, PhD, University of Pennsylvania).

Additionally, updated data on the previously-published B-cell signature from the ITN507ST “Study of tolerant kidney transplant recipients,” including the presence of the signature in a new cohort of tolerant patients and the stability of the signature over time, will be reported in the abstract:

  • Refinements of the transcriptional B cell ‘signature’ associated with clinically tolerant renal transplant recipients (Kenneth Newell, MD, PhD, Emory University).

More Information

Attached PDF